← Back to CVE intelligence
CVE intelligenceCISA KEV

CVE-2026-123218

IBM Aspera Faspex Incorrect Authorization Vulnerability

Published Nov 7, 2026Sources checked Nov 20, 2026
9.8CRITICALCVSS out of 10
What this means

Actively exploited

CISA lists CVE-2026-123218 in its Known Exploited Vulnerabilities catalog, which means exploitation has been observed. The entry applies to IBM Aspera Faspex.

  • Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
CISA KEVListedObserved exploitation
EPSS0.5%Estimated 30-day exploitation probability
Ransomware useNot markedCISA KEV ransomware field
Threat actors1Source-linked actor relationships
Overview

What is CVE-2026-123218?

IBM Aspera Faspex 5.0.0 through 5.0.19 could allow an authorized user to craft a specific message to bypass user authorization and gain full administrative privileges.

Source: NVD

CISA says:Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.CISA catalog due date Nov 12, 2026